illumi. Fit

A pharmaceutical company

Our Mission

illumi. Fit, specializes in sourcing Active Pharmaceutical Ingredients (APIs) for Semaglutide and Tirzepatide—revolutionary treatments for diabetes and obesity. We are dedicated to providing high-quality, effective, and safe pharmaceutical products through rigorous sourcing and strict quality control measures. As a subsidiary of True Family Enterprises, we leverage our extensive experience and trusted supplier network to ensure our products meet the highest standards.

Our Product

We are offer Semaglutide and Tirzepatide APIs that are produced in FDA-approved manufacturing facilities, ensuring that our products meet the highest standards of quality and safety. Our APIs are fully compliant with both U.S. and E.U. regulations, giving you peace of mind that you are receiving pharmaceutical ingredients that adhere to the strictest global standards. To ensure the integrity of these temperature-sensitive products, we provide door-to-door shipping in a temperature-controlled enclosure, safeguarding the quality of the APIs from our facility to your doorstep.

 
 
 

 In addition, we offer Multi-dose Injection Pen Sets that provide a unique branding opportunity for high-volume compounders. These sets are designed to present your products in a professional, market-ready format, ideal for those looking to transition from traditional vials to injection pens using automated fillers. Each set includes a custom-branded box, giving your product a polished appearance that enhances brand recognition and adds value to your offerings in the competitive marketplace.

Our Market

The market for Semaglutide is projected to reach USD 21 billion in 2024 and expand to USD 33 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.20%. This growth underscores the increasing demand for effective diabetes treatments as the condition continues to be one of the fastest-growing global health emergencies.

 
 

State-of-the-Art Manufacturing

Our manufacturing partners are at the forefront of the pharmaceutical industry, producing top-quality products in state-of-the-art GMP (Good Manufacturing Practice) facilities. These facilities are equipped with the latest technology and operate under rigorous quality control systems to ensure that every product meets the highest standards of safety, efficacy, and purity. 

 

We are committed to working only with manufacturers who share our dedication to patient care, integrity, and excellence. Our partners are carefully selected for their ability to maintain a flawless record of compliance, with Drug Master Files (DMF) and Establishment Inspection Reports (EIR) readily available on file. This ensures that every product we offer not only meets regulatory requirements but also exceeds industry expectations for quality and reliability. 

 

By partnering with us, you can be confident that you are sourcing pharmaceutical products from a network of manufacturers who are not just compliant, but who consistently aim for zero errors and the highest level of precision in their production processes.

Our Competitive Advantage

illumi. Fit stands out in the market due to our competitive pricing, superior service, and flexibility. Our world-class quality management system and multiple quality certifications reflect our commitment to excellence. We partner with wholesalers and compounders fully equipped and authorized to distribute Semaglutide and Tirzepatide, ensuring broad market reach.

Partner With Us

At illumi. Fit, we are more than just a supplier—we are your strategic partner in navigating the complexities of pharmaceutical sourcing. Our tailored solutions are designed to meet your unique requirements, helping you grow your business effectively.

Contact Us

For more information or to discuss partnership opportunities, please reach out to:

info@illumi.fit

Join us in our mission to transform diabetes and obesity treatments and make a significant impact on global health.